On the basis of the continuous innovation and development of the existing traditional pharmaceutical industry, we will promote the construction of Guangzhou Baiyun Biomedical and Health Industry Base and strive to promote the accelerated agglomeration and development of the big h

2025/05/1323:47:34 hotcomm 1873

In recent years, Big Health Biomedical , as an emerging industry, has good development prospects and vigorous vitality, and has even attracted enough attention from the national level. In order to actively respond to the country's call to cultivate emerging biomedical industries, and to occupy a place in this industrial map with unlimited potential, we will promote the construction of Guangzhou Baiyun Biomedical and Health Industry Base on the basis of the continuous innovation and development of the existing traditional pharmaceutical industry, and strive to promote the accelerated agglomeration and development of the big health biomedical industry in the whole region.

On the basis of the continuous innovation and development of the existing traditional pharmaceutical industry, we will promote the construction of Guangzhou Baiyun Biomedical and Health Industry Base and strive to promote the accelerated agglomeration and development of the big h - DayDayNews

Baiyun District , which has good resource endowment, industrial foundation and market potential, has a place in this industry map with unlimited potential, and is promoting the construction of Guangzhou Baiyun Biomedical and Health Industry Base on the basis of the continuous innovation and development of the existing traditional pharmaceutical industry , and vigorously promote the accelerated agglomeration and development of the big health biomedical industry in the whole region. This year, 29 major health biomedical investment promotion projects in Baiyun District, , with an estimated annual output value revenue of 30 billion yuan.

The traditional biopharmaceutical industry has been constantly innovating and striving to move forward

"Guangyao Baiyunshan , love fills the world." This classic advertising slogan has allowed the whole country to know Baiyunshan and Baiyun District in the past 40 years. Nowadays, when it comes to the big health biopharmaceutical industry in Baiyun District, the first thing that comes to mind is the Baiyunshan Pharmaceutical General Factory, Hutchison Traditional Chinese Medicine and other pharmaceutical resources that have been rooted in Baiyun for a long time. They are all concentrated in Jingxi and Tonghe areas.

Today, the Baiyun District Big Health Biopharmaceutical Industry Chain is still dominated by traditional business formats. The Baiyun District Investment Promotion Office introduced that its focus covers pharmaceutical manufacturing and circulation, medical and health institutions, R&D education institutions, elderly care and rehabilitation institutions, pharmaceutical and medical equipment retail, and electronic logistics, mainly pharmaceutical manufacturing and distribution enterprises, pharmaceutical and medical equipment retail enterprises.

At present, Baiyun District has a number of national or provincial and municipal key pharmaceutical companies represented by Guangzhou Pharmaceutical Group, such as Wanglaoji Pharmaceutical, Hutchison Traditional Chinese Medicine, Huahan Pharmaceutical, Baiyunshan Pharmaceutical Factory, He Jigong Pharmaceutical Factory, Kangaiduo, Infinitus, Guangdong Bencai Pharmaceutical, Mait Xinghua Pharmaceutical, etc. Today, there are 6 pharmaceutical manufacturing enterprises above the designated size in the district, with a total output value of 3.162 billion yuan last year, accounting for 4.62% of the total output value above the designated size in the district. Among them, there are three leading enterprises with an output value of 1.43 billion yuan, namely Wanglaoji Pharmaceutical with an output value of 1.39 billion yuan, Baiyunshan Hutchison Whampoa with an output value of 1.39 billion yuan, and Guangdong Huahan Pharmaceutical with an output value of 100 million yuan.

Whether in the past or present, the traditional big health biopharmaceutical industry in Baiyun District plays an important role in the city's biopharmaceutical industry map. In recent years, with the popularity of Guangzhou's vigorous promotion of the "IAB" plan, many biopharmaceutical companies have settled in me. This year, biopharmaceutical companies such as Jiuzhoutong Group, Liancun Technology, and Baorui Medical R&D have continued to pour into our district.

Judging from the medical map of Baiyun District, Jingxi and Tonghe areas are still resource concentration points. In Tonghe Street , its strong health industry units such as Baiyunshan Pharmaceutical Factory, Baiyunshan Hutchison Huangpu, Baiyunshan Chemical Pharmaceutical Factory, Guangzhou Sanatorium and Baiyunshan Hospital gathered to create the only "Guangdong Province Biomedical Professional Street" in Guangzhou. In April last year, when the main leaders of the Baiyun District Committee visited the street for investigation, they made industrial plans and deployments for the street to "benchmark Tianhe and develop headquarters economy". In Jingxi Street, the same is true. The street has more than 20 "four-top" enterprises in the medical industry. Last year, the tax payment treasury of these enterprises reached 120 million yuan.

Nowadays, Jingxi and Tonghe regions have been positioned as green and healthy ecological groups in the eastern Baiyun District. They are using Southern Hospital , 157 Hospital, Baiyunshan Pharmaceutical Factory, Hutchison Whampoa and other rich medical resources to build an ecological and medical health base in the eastern Baiyunshan. On the basis of superior ecological resources, they are starting to develop green industries such as health services, leisure tourism and pharmaceutical manufacturing.

hotcomm Category Latest News